<?xml version="1.0" encoding="UTF-8"?>
<p>With historical precedents and recent clinical studies, convalescent plasma therapy should be considered as a candidate intervention for COVID-19, given the limited evidence of effectiveness of antiviral agents and the lack of a vaccine. A system to secure safe collection and use of convalescent plasma should be developed as a response to the pandemic. Further scientific studies on the safety and effectiveness of convalescent plasma therapy should be explored through clinical trials that can be established concurrently with the clinical use of convalescent plasma therapy.</p>
